Cardiovascular Care & Cognitive Health: New Research aims to Align treatments with Patient Priorities
Table of Contents
A growing body of research suggests a critical link between standard heart treatments adn cognitive function,prompting a new wave of examination into how to best serve aging patients. While life-extending therapies are vital, a new initiative is focused on ensuring those treatments also preserve quality of life, independence, and mental acuity.
A recent award is fueling research into the potential impact of common cardiovascular medications – including beta blockers and calcium channel blockers – on cognitive status over time. Currently, these effects are not routinely measured during cardiovascular clinical trials.
Bridging the Gap in Cardiac Care
“Many of the standard treatments we deliver to patients have potential or hypothesized impacts on cognition, but it’s not something that is measured,” a senior researcher explained. “We are hopeful we can add to the evidence base to help doctors and patients find treatments that reflect the patients’ goals.”
This research comes as the HeartWise Lab, recently launched with colleague Dr. Abdulla Damluji, seeks to address a critical gap in patient care. The lab’s work is driven by the understanding that extending lifespan is only one piece of the puzzle. Maintaining a patient’s ability to function, remain autonomous, and enjoy a high quality of life are equally critically important considerations, notably for older adults.
To that end, the team is also developing “Consider, Listen, decide,” a shared decision-making tool funded by the prestigious Pepper Scholar Award. This tool is specifically designed to help older adults navigate the complex choices surrounding coronary disease treatment.
The need for such a tool is underscored by recent findings. A review published in the Journal of the American College of Cardiology (JACC) examined the prevalence of cognitive impairment among cardiac patients and identified evidence-based management strategies to mitigate these issues.
Addressing Cognitive Decline in cardiac Patients
the research highlights the importance of recognizing and addressing cognitive challenges that frequently enough accompany heart conditions. The goal, researchers emphasize, is to move beyond simply treating the heart and to adopt a more holistic approach that considers the patient’s overall well-being.
“We want to ensure that therapies not only extend life but also preserve patients’ function, independence, and quality of life,” the researcher stated. This commitment to patient-centered care represents a meaningful shift in the landscape of cardiovascular medicine, promising a future where treatments are tailored to individual needs and priorities.
Here’s a substantive news report answering the “Why, Who, What, and How” questions:
Why: A growing body of research reveals a link between heart treatments and cognitive decline, prompting a need to balance lifespan extension with quality of life.
Who: Researchers at the newly launched HeartWise Lab, led by a senior researcher and Dr. Abdulla Damluji, are spearheading this effort. The work also builds on a review published in the Journal of the American College of cardiology (JACC).
What: The initiative involves research into the cognitive impacts of common cardiovascular medications (beta blockers, calcium channel blockers) and the development of a shared decision-making tool, “Consider, Listen, Decide,” to help older adults navigate coronary disease treatment options. The Pepper Scholar Award is funding the
